Are you or your loved ones suffering from solid tumors?

You may be eligible to participate in a solid tumors clinical trial.

Are you or your loved ones suffering from solid tumors? You may be eligible to participate in a solid tumors clinical trial.

What is a clinical trial? Is participating in a clinical trial right for you? Learn more

Recruiting for this study? Get access to patient recruitment tools.
Solid Tumors in New Brunswick NJ
NCT02250781 | Phase 1 | Interventional

Are you or your loved ones suffering from solid tumors?

You may be eligible to participate in a solid tumors clinical trial.

Are you or your loved ones suffering from solid tumors? You may be eligible to participate in a solid tumors clinical trial.

Suspended

Male & Female

18 +

years old

This study is looking to recruit 30 Participants

This phase I trial studies the side effects and best dose of Oral ONC201 in treating patients with advanced solid tumors. Oral ONC201 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

Selected location

Rutgers Cancer Institute of New Jersey

Rutgers Cancer Institute of New Jersey Change

195 Little Albany Street, New Brunswick, NJ, USA 08903 Map | Learn more
Interested in participating?
Selected location

Rutgers Cancer Institute of New Jersey

195 Little Albany Street, New Brunswick, NJ, USA 08903

Jyoti Malhotra 732-235-7521
jyoti.malhotra@rutgers.edu


This location is not recruiting at the moment.